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Introduction
Vascular endothelial dysfunction can initiate oxidative stress, i.e.
superoxide (SO) overproduction, during ischemia/reperfusion (I/R).
Endothelial dysfunction is characterized by an increase of oxidative stress,
leading to an increase in blood hydrogen peroxide (H2O2) and a decrease
in endothelial-derived nitric oxide (NO) bioavailability. Leukocyte NADPH
oxidase is well studied; however, endothelial NADPH oxidase contributing
to I/R injury is not well characterized. Previous studies using Gö 6983, a
broad-spectrum protein kinase C inhibitor that can inhibit NADPH oxidase
activity, has attenuated blood H2O2 levels during femoral I/R in vivo (1,2). A
selective NADPH oxidase inhibitor, apocynin (Fig. 1), interrupts the
intracellular assembly of the enzyme by preventing the translocation to the
cell membrane (Fig. 2). Specifically, apocynin blocks the Cys196 residue
interaction between endothelial NADPH oxidase subunits p47phox and p22phox
(Fig. 3). This in turn inhibits SO release from endothelial NADPH oxidase,
which further enhances endothelial-derived NO release both of which may
reduce oxidative stress in I/R injury (3,4).

Hypothesis
We hypothesize that the femoral I/R vein will show an increase in blood H2O2
release compared to its counterpart sham femoral vein. Whereas, a decrease
in NO release is expected in the femoral I/R vein compared to the sham vein
of saline control animals. When the direct NADPH oxidase inhibitor, apocynin
(T1/2 3h), is given at the beginning of reperfusion we predict a decrease in
H2O2 release and an increase in endothelial-derived NO bioavailability
compared to saline control group.

Methods
We measured H2O2 or NO release in real-time from femoral veins of the
anesthetized rat: one limb subjected to I/R while the other was used as a
non-ischemic sham control. The H2O2 or NO microsensors (100 um, WPI
inc.) were connected to a free radical analyzer (Apollo 4000, WPI inc.) and
were inserted into a catheter placed inside each femoral vein. Ischemia of
femoral circulation in one limb was induced by clamping the femoral
artery/vein for 20 minutes followed by 45 minutes of reperfusion. Apocynin
(13.7 mg/kg, diluted in saline ~ 1 mM in blood) or saline (for non-drug
control group) was administered through a juglar vein cannulation at the
beginning of reperfusion. Experimental groups were compared with student ttest.

Figure 6. Comparison of the relative difference in H2O2 release between I/R
and sham femoral veins during reperfusion. There was a significant
decrease in H2O2 release in the apocynin-treated group compared to saline
from 20 minutes to 45 minutes of reperfusion (* p<0.05, **p<0.01 from
saline).

Figure 1. Apocynin (acetovallinone) molecular structure. Molar Mass: 166.2.
T1/2 of hours. Sigma Chemicals.
Figure 4. The experimental preparation for measuring H2O2 or NO release
from male Sprague-Dawley rats (275-325 grams, Ace Animals, Boyertown,
PA) femoral veins.
We continuously recorded the H2O2 or NO release and collected the data at 5
minute intervals during a 15 minute baseline period, 20 minute ischemia and
45 minute reperfusion. The changes in H2O2 or NO release during I/R (in pA)
were expressed as relative change to baseline H2O2 (uM) or NO (nM) after
correction to the calibration curve of H2O2 or NO microsensors.

Results
b

Figure 7. Comparison of the relative difference in NO bioavailability between
I/R and sham femoral veins during reperfusion. There was a significant
increase in NO release in the apocynin-treated group compared to saline
from 20 minutes to 45 minutes of reperfusion (* p<0.05, **p<0.01 from
saline).

Conclusions
When apocynin is given at the beginning of reperfusion, there is a significant
reduction of blood H2O2 and a significant increase in endothelial-derived NO
bioavailablity compared to the saline group. Apocynin has reportedly been
successful in preventing Cys196 interaction between the endothelial NADPH
oxidase subunits p47phox and p22phox, which is necessary for NADPH oxidase
assembly at the cell membrane. By preventing NADPH oxidase assembly
under I/R conditions, SO production should decrease, thus leading to a
decrease in H2O2 and an increase of endothelial-derived NO bioavailability.
This inhibition appears to be consistent with our findings, suggesting that
endothelial NADPH oxidase is a major contributor to oxidative stress in this
model of I/R injury since only resident leukocytes are present during this time
course.

Figure 2. Apocynin inhibits endothelial NADPH oxidase subunits p47phox and
p22phox assembly, preventing the production of SO. Adapted from Morena M
et al. 2002 (5).

Figure 3. Apocynin interrupts the Cys196 interaction between NADPH oxidase
subunits p47phox and p22phox, preventing enzyme assembly and SO
generation. Adapted from Mora-Pale et al, 2012 (4).

Figure 5. The time course of change in H2O2 (uM) or NO (nM) release from
femoral veins during reperfusion in the saline control group.
(a) There was a significant increase in H2O2 release from I/R veins compared
to sham veins during reperfusion (* p<0.05, **p<0.01 from sham).
(b) There was no significant difference in NO release from I/R veins
compared to sham during reperfusion (* p<0.05, **p<0.01 from sham).
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